Keywords
chronic obstructive pulmonary disease
adherence to treatment
How to Cite
Abstract
Chronic obstructive pulmonary diseases are among the most common in the world. Bronchial asthma (BA) and chronic obstructive pulmonary disease (COPD) limit our patients' ability to work, reduce their ability to work, and require considerable financial costs. However, today we have the opportunity to help these patients by prescribing affordable and effective medications. However, some patients fail to achieve disease control. A common reason for this is poor adherence to treatment.
The aim of the study: to determine adherence to treatment and its impact on the c ourse of the disease.
Materials and methods. The study included 52 patients with bronchial asthma and chronic obstructive pulmonary disease. The severity of the disease was determined using the Moderate Dyspnea Rating Scale (MRC) and spirometric parameters. Adherence to treatment was assessed using a 7-question questionnaire.
Results. The test results were evaluated at the first visit, 3 and 6 months after the start of treatment. After 6 months, the mean MRC scores improved in both groups, but in the asthma group, the number of patients who rated their dyspnea as severe was significantly lower (7 patients in the COPD group and 2 patients in the asthma group). Adherence to treatment was not significantly different in both groups (4.5±0.1 points vs. 4.2±0.3 points, p<0.05). The main factors affecting adherence are the price of the drug, the duration of use, and possible side effects
References
Nguyen Thang, Truong Mai Thi Xuan, Lam Dung Ngoc, Nguyen Huong Thi Thu, Huynh Anh Mai, Duong Vy Khanh. Effectiveness of clinical pharmacist intervention on medication adherence in patients with chronic obstructive pulmonary disease − A randomized controlled study. Patient Educ Couns. 2024 Jan:118:108037. doi: 10.1016/j.pec.2023.108037
Leving MT, Bosnic-Anticevich S, van Cooten J, Correia de Sousa J, Cvetkovski B, Dekhuijzen R. Clinical recommendations for dry powder inhaler use in the management of COPD in primary care. NPJ Prim Care Respir Med. 2022 Dec 27;32(1):59. doi: 10.1038/s41533-022-00318-3
Yorke Janelle, Khan Naimat, Garrow Adam, Tyson Sarah, Singh Dave et al. Evaluation of the Individual Activity Descriptors of the mMRC Breathlessness Scale: A Mixed Method Study. Int J Chron Obstruct Pulmon Dis. 2022 Sep 15:17:2289-2299. doi: 10.2147/COPD.S372318. eCollection 2022
Zhou Jin, Yang Xuhao, Zhou Jiaqing, Xiong Maoyu, Wen Li. Efficacy of medical education combined with extended care on adherence to inhaled glucocorticoids and clinical effects in patients with bronchial asthma. J Asthma. 2024 Oct 17:1-8. doi: 10.1080/02770903.2024.2410423
Živanović Dejan, Javorac Jovan, Savić Dejana, Mikić Andrijana, Jevtić Marija, Ilić Miroslav, Kolarov Violeta et al. Adherence, Disease Control, and Misconceptions Related to the Use of Inhalation Therapy in Patients with Obstructive Pulmonary Diseases: A Cross-Sectional Study. Medicina (Kaunas). 2024 May;23;60(6):853. doi: 10.3390/medicina60060853
Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999 Jul;54(7):581-6. doi: 10.1136/thx.54.7.581
Świątoniowska Natalia, Chabowski Mariusz, Polański Jacek, Mazur Grzegorz, Jankowska-Polańska Beata. Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review. Adv Exp Med Biol. 2020:1271:37-47. doi: 10.1007/5584_2019_477